相似文献
1
The licensing of DNA patents by US academic institutions: an empirical survey.
Nat Biotechnol. 2006 Jan;24(1):31-9. doi: 10.1038/nbt0106-31.
2
DNA patenting: the end of an era?
Nat Biotechnol. 2007 Feb;25(2):185-7. doi: 10.1038/nbt0207-185.
3
Survey reveals US university licensing up, startup formation down.
Nat Biotechnol. 2005 Feb;23(2):261-2. doi: 10.1038/bioent843.
4
Gene patents push labs to their limits.
CAP Today. 1999 Mar;13(3):1, 30-2, 34, passim.
5
Impact of gene patenting on R&D and commerce.
Nat Biotechnol. 2003 Jul;21(7):729-31; author reply 731. doi: 10.1038/nbt0703-729.
6
The prevalence of patent interferences in gene technology.
Nat Biotechnol. 2004 Feb;22(2):153-4. doi: 10.1038/nbt0204-153.
7
European Commission rethinks biotech patents.
Nat Biotechnol. 2002 Dec;20(12):1175-6. doi: 10.1038/nbt1202-1175.
8
A pilot survey on the licensing of DNA inventions.
J Law Med Ethics. 2003 Fall;31(3):442-9. doi: 10.1111/j.1748-720x.2003.tb00107.x.
9
DNA patents and diagnostics: not a pretty picture.
Nat Biotechnol. 2010 Aug;28(8):784-91. doi: 10.1038/nbt0810-784.
10
Is India's 'patent factory' squandering funds?
Nature. 2006 Jul 13;442(7099):120. doi: 10.1038/442120a.
引用本文的文献
1
NIH inventions translate into drugs and biologics with high public health impact.
Nat Biotechnol. 2014 Jan;32(1):52-8. doi: 10.1038/nbt.2785.
2
Not quite a myriad of gene patents.
Nat Biotechnol. 2013 May;31(5):404-10. doi: 10.1038/nbt.2568.
3
One community's effort to control genetic disease.
Am J Public Health. 2012 Jul;102(7):1300-6. doi: 10.2105/AJPH.2011.300569. Epub 2012 May 17.
4
An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.
Milbank Q. 2011 Sep;89(3):450-502. doi: 10.1111/j.1468-0009.2011.00636.x.
5
Patent pools and clearinghouses in the life sciences.
Trends Biotechnol. 2011 Nov;29(11):569-76. doi: 10.1016/j.tibtech.2011.06.002. Epub 2011 Jul 4.
6
DNA patents and diagnostics: not a pretty picture.
Nat Biotechnol. 2010 Aug;28(8):784-91. doi: 10.1038/nbt0810-784.
7
Myriad Genetics: In the eye of the policy storm.
Genet Med. 2010 Apr;12(4 Suppl):S39-70. doi: 10.1097/GIM.0b013e3181d72661.
8
Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis.
Genet Med. 2010 Apr;12(4 Suppl):S194-211. doi: 10.1097/GIM.0b013e3181d7cf7d.
9
Proprietary science, open science and the role of patent disclosure: the case of zinc-finger proteins.
Nat Biotechnol. 2009 Feb;27(2):140-4. doi: 10.1038/nbt0209-140.
10
Evidence and anecdotes: an analysis of human gene patenting controversies.
Nat Biotechnol. 2006 Sep;24(9):1091-4. doi: 10.1038/nbt0906-1091.
本文引用的文献
1
Intellectual property. Enhanced: intellectual property landscape of the human genome.
Science. 2005 Oct 14;310(5746):239-40. doi: 10.1126/science.1120014.
2
Science and law. View from the bench: patents and material transfers.
Science. 2005 Sep 23;309(5743):2002-3. doi: 10.1126/science.1115813.
3
Intellectual property. Patents on human genes: an analysis of scope and claims.
Science. 2005 Mar 11;307(5715):1566-7. doi: 10.1126/science.1105162.
4
Gene patents: the need for bioethics scrutiny and legal change.
Yale J Health Policy Law Ethics. 2005 Winter;5(1):403-12.
5
Intellectual property. NIH roils academe with advice on licensing DNA patents.
Science. 2004 Mar 19;303(5665):1757-8. doi: 10.1126/science.303.5665.1757a.
6
Effects of patents and licenses on the provision of clinical genetic testing services.
J Mol Diagn. 2003 Feb;5(1):3-8. doi: 10.1016/S1525-1578(10)60444-8.
7
Making dollars out of DNA. The first major patent in biotechnology and the commercialization of molecular biology, 1974-1980.
Isis. 2001 Sep;92(3):541-75. doi: 10.1086/385281.
8
Can patents deter innovation? The anticommons in biomedical research.
Science. 1998 May 1;280(5364):698-701. doi: 10.1126/science.280.5364.698.
9
Structure and function in gene patenting.
Nat Genet. 1997 Feb;15(2):125-30. doi: 10.1038/ng0297-125.
Zotero 插件